Skip to content

The effect of Matricaria Chamonail on postpartum depression

The effect of Matricaria Chamonail on postpartum depression

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211207053313N1
Enrollment
144
Registered
2021-12-12
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression.

Interventions

Intervention 1: Intervention group: People will be advised to take two capsules of 500 mg of chamomile extract daily. Patients will be contacted twice a week. at the first visit, capsules will be give

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having a cell phone Women with mild to moderate depression who are in the second week after delivery until 6 months later. Term, single and alive baby delivery Being literate Age 18 to 45 years Women with mild to moderate depression who are in the second week after delivery until 6 months later.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The average score of depression. Timepoint: Before the intervention nd 8 weeks after the start of treatment. Method of measurement: Beck Depression questionnaire.;The severity of depression. Timepoint: Before the intervention and 8 weeks after the start of treatment. Method of measurement: Beck depression questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eradi

Ahvaz University of Medical Sciences

eradi.m@ajums.ac.ir+98 61 4223 1706

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026